Yes it's clearly a bet that those shares are going to be worth much more than cash in the LT. So paying out the cash is in the best interests of shareholders, I quite agree.
It's worthwhile to try to look at what the most realistic outcome is for AHZ with such technology and the market size.
There have been a lot of posts on this topic and it's worthwhile to look back and fully digest them. Along with the human trials information. Peer review is going to drive this very high. IMO.
My take is looking not at the optimal you once were shooting for, and look at what's realistic. TAVR is clearly the most lucrative, SAVR will be a huge part of the marketing with peers. TAVR is obviously the less invasive of the methods of delivery.
I can't see the risks here being substantial at all.
Thanks for the contributions David G, great to see you back!
Ann: Notice of Extraordinary General Meeting/Proxy Form, page-81
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |